Why Changing Marijuana's DEA Categorization Could Be 'The Most Consequential Action Out Of DC'
Portfolio Pulse from Joana Scopel
Kris Krane, director of cannabis development for KCSA Strategic Communications and founder of 4Front Ventures Corp., called for a review of marijuana's scheduling under the Controlled Substances Act in a recent interview at the Benzinga Cannabis Capital Conference. Krane urged President Joe Biden, the FDA, and other relevant agencies to consider de-scheduling marijuana or moving it to a lower schedule. He emphasized that such a move could be a game-changer for the cannabis industry.
July 21, 2023 | 6:05 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
4Front Ventures Corp., a cannabis company, could benefit significantly if marijuana is de-scheduled or moved to a lower schedule under the Controlled Substances Act.
As a company in the cannabis industry, 4Front Ventures stands to benefit from any regulatory changes that make it easier to produce, sell, or use marijuana. If marijuana is de-scheduled or moved to a lower schedule, it could lead to increased business opportunities and growth for 4Front Ventures.
CONFIDENCE 75
IMPORTANCE 90
RELEVANCE 80